|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
9,860,000 |
Market
Cap: |
4.34(M) |
Last
Volume: |
343,990 |
Avg
Vol: |
274,696 |
52
Week Range: |
$0.258 - $0.76 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,283,690 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,979,170 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
5 |
Total Shares Sold |
0 |
0 |
3,747,968 |
3,747,968 |
Total Sell Value |
$0 |
$0 |
$4,610,000 |
$4,610,000 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
2 |
2 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bucalo Louis R Md |
President and CEO |
|
2007-05-03 |
4 |
B |
$2.38 |
$19,111 |
D/D |
8,000 |
508,000 |
2.81 |
- |
|
Farrell Robert Edward |
Exec Vice President and CFO |
|
2007-04-27 |
4 |
B |
$2.14 |
$33,170 |
D/D |
15,500 |
111,580 |
2.74 |
- |
|
Farrell Robert Edward |
Exec Vice President and CFO |
|
2007-03-20 |
4 |
B |
$2.29 |
$61,837 |
D/D |
26,000 |
96,080 |
2.74 |
- |
|
Weis Konrad M Phd |
Director |
|
2006-03-10 |
4 |
OE |
$1.71 |
$39,544 |
D/D |
23,125 |
58,699 |
|
- |
|
Allen Richard C |
officerTitle |
|
2005-12-06 |
4 |
S |
$1.30 |
$60,904 |
D/D |
(46,488) |
0 |
|
- |
|
Allen Richard C |
officerTitle |
|
2005-12-05 |
4 |
S |
$1.39 |
$21,356 |
D/D |
(15,000) |
46,488 |
|
- |
|
Allen Richard C |
officerTitle |
|
2005-12-02 |
4 |
S |
$1.41 |
$28,611 |
D/D |
(20,000) |
61,488 |
|
- |
|
Allen Richard C |
officerTitle |
|
2005-12-01 |
4 |
S |
$1.44 |
$10,156 |
D/D |
(6,800) |
81,488 |
|
- |
|
Bhonsle Sunil |
EVP and COO |
|
2005-11-07 |
4 |
B |
$1.40 |
$43,000 |
D/D |
30,000 |
59,400 |
2.81 |
- |
|
Bhonsle Sunil |
EVP & COO |
|
2005-11-03 |
4/A |
B |
$1.52 |
$15,048 |
D/D |
9,900 |
29,400 |
2.81 |
- |
|
Bhonsle Sunil |
EVP and COO |
|
2005-11-03 |
4 |
B |
$1.52 |
$15,048 |
D/D |
9,900 |
90,294 |
2.81 |
- |
|
Bucalo Louis R Md |
President & CEO |
|
2005-11-01 |
4 |
B |
$1.66 |
$5,859 |
D/D |
3,514 |
500,000 |
2.81 |
- |
|
Huckel Hubert E Md |
Director |
|
2005-10-24 |
4 |
B |
$1.68 |
$44,339 |
D/D |
25,700 |
62,200 |
2.39 |
- |
|
Farrell Robert Edward |
Executive VP and CFO |
|
2005-10-17 |
4 |
B |
$1.70 |
$13,940 |
D/D |
8,200 |
71,780 |
2.74 |
- |
|
Farrell Robert Edward |
Executive VP and CFO |
|
2005-10-14 |
4 |
B |
$1.68 |
$168 |
D/D |
100 |
63,580 |
2.66 |
- |
|
Farrell Robert Edward |
Executive VP and CFO |
|
2005-10-13 |
4 |
B |
$1.64 |
$25,897 |
D/D |
15,700 |
63,480 |
2.74 |
- |
|
Bucalo Louis R Md |
Pres. & Chief Exec. Officer |
|
2005-10-06 |
4 |
B |
$1.69 |
$105,392 |
D/D |
62,000 |
496,486 |
2.81 |
- |
|
Allen Richard C |
Executive Vice President |
|
2005-10-03 |
4 |
OE |
$1.35 |
$78,173 |
D/D |
57,906 |
88,288 |
|
- |
|
Bhonsle Sunil |
EVP and COO |
|
2005-08-16 |
4/A |
B |
$2.20 |
$5,500 |
D/D |
2,500 |
19,500 |
2.81 |
- |
|
Allen Richard C |
Executive Vice President |
|
2005-01-05 |
4 |
OE |
$0.08 |
$2,049 |
D/D |
25,617 |
30,382 |
|
- |
|
Bucalo Louis R Md |
President and CEO |
|
2004-08-16 |
4 |
B |
$2.20 |
$5,500 |
D/D |
2,500 |
434,486 |
2.81 |
- |
|
Bhonsle Sunil |
Executive VP and COO |
|
2004-08-16 |
4 |
B |
$2.20 |
$5,500 |
D/D |
2,500 |
180,394 |
2.81 |
- |
|
Bauer Victor J Phd |
Director |
|
2004-08-16 |
4 |
S |
$2.20 |
$11,000 |
D/D |
(5,000) |
8,644 |
|
- |
|
Bucalo Louis R Md |
President and CEO |
|
2004-02-09 |
4 |
OE |
$0.59 |
$48,235 |
D/D |
81,755 |
431,986 |
|
- |
|
Weis Konrad M Phd |
Director |
|
2003-11-26 |
4 |
OE |
$0.59 |
$2,999 |
D/D |
5,117 |
35,574 |
|
- |
|
131 Records found
|
|
Page 5 of 6 |
|
|